Different CFTR Mutational Spectrum in Alcoholic and Idiopathic Chronic Pancreatitis?

Pancreas

Volumn 28, Issue 4, 2004, Pages 374-379

  Casals, Teresa ^a,f   Aparisi, Luís ^b   Martínez Costa, Cecilia ^c   Giménez, Javier ^a   Ramos, Maria D ^a   Mora, Josefina ^d   Diaz, Juan ^g   Boadas, Jaume ^c   Estivill, Xavier ^a,e   Farré, Antoni ^c  

^a Institut de Recerca Oncologica   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d HOSPITAL SANT PAU   (Spain)

^e CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^f HOSPITAL DURAN I REYNALS   (Spain)

^g NONE

Author keywords

CFTR gene; CFTR related disease; Chronic pancreatitis; Mutational analysis

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ALCOHOLIC PANCREATITIS; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; DISEASE COURSE; EVALUATION; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; IDIOPATHIC DISEASE; MALE; PANCREAS CALCIFICATION; PANCREAS PSEUDOCYST; PATIENT CODING; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; TOBACCO;

ADULT; AGED; CHRONIC DISEASE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATITIS; PANCREATITIS, ALCOHOLIC;

EID: 11144356282     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200405000-00004     Document Type: Article

References (30)

1. Samer M, Cotton PB. Classification of pancreatitis. Gut. 1984;25:756-759.
2. Bisceglie AM, Segal I. Cirrhosis and chronic pancreatitis in alcoholics. J Clin Gastroenterol. 1984;6:199-200.
3. Kerem BS, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245:1073-1080.
4. Welsh MJ, Ramsey BW, Accurso F, et al. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, Inc.; 2001:5121-5188.
5. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066-1073.
6. Kopelman H, Durie P, Gaskin K, et al. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Engl J Med. 1985;312:329-333.
7. Dumo C, Corey M, Zielenski J, et al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology. 2002;123:1857-1864.
8. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998;339:653-658.
9. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998;339:645-652.
10. Ockenga J, Stuhrmann M, Ballmann M, et al. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol. 2000;95:2061-2067.
11. Truninger K, Malik N, Ammann RW, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. Am J Gastroenterol. 2001;96:2657-2661.
12. Noone PG, Zhou Z, Silverman LM, et al. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterol. 2001;121:1310-1319.
13. Castellani C, Gomez Lira M, Frulloni L, et al. Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in idiopathic pancreatitis. Hum Mutat. 2001;18(2):166.
14. Audrezet MP, Chen JM, Le Marechal C, et al. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet. 2002;10:100-106.
15. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682-707.
16. Costes B, Fanen P, Goossens M, et al. A rapid, efficient and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations. Hum Mutat. 1993;2:185-191.
17. Casals T, Ramos MD, Gimenez J, et al. High heterogeneity for cystic fibrosis in spanish families: 75 mutations account for 90% of chromosomes. Hum Genet. 1997;101:365-370.
18. Cuppens H, Teng H, Raeymaekers P, et al. CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet. 1994;4:607-614.
19. Casals T, Bassas LI, Egozcue S, et al. Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum Reprod. 2000;15:1476-1483.
20. Bombieri C, Giorgi S, Carles S, et al. New approach for identifying nonpathogenic mutations. An analysis of the cystic fibrosis transmembrane regulator gene in normal individuals. Hum Genet. 2000;106:172-178.
21. Dörk T, Dwomiczak B, Aulehla-Scholz C, et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997;100:365-377.
22. Gomez Lira M, Benetazzo MG, Marzari MG, et al. High frequency of cystic fibrosis transmembrane regulator mutation L997F in patients with recurrent idiopathic pancreatitis and in newborns with hypertrypsinemia. Am J Hum Genet. 2000;66:2013-2014.
23. Norton ID, Apte MV, Dixson H, et al. Cystic fibrosis genotypes and alcohol pancreatitis. J Gastroenterol Hepatol. 1998;13:496-499.
24. Monaghan KG, Jackson CE, Kukuruga DL, et al. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet. 2000;94:120-124.
25. Haber PS, Norris MD, Apte MV, et al. Alcoholic pancreatitis and polymorphisms of the variable length polythymidine tract in the cystic fibrosis gene. Alcohol Clin Exp Res. 1999;23:509-512.
26. Malats N, Casals T, Porta M, et al. Cystic fibrosis transmembrane regulator (CFTR) F508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. Gut. 2001;48:70-74.
27. Cuppens H, Lin W, Jaspers M, et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest. 1998;101:487-496.
28. Teng H, Jorissen M, Van Poppel H, et al. Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Molec Genet. 1997;6:85-90.
29. Mak V, Jarvi KA, Zielenski J, et al. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum Molec Genet. 1997;6:2099-2107.
30. Tizzano EF, Chitayat D, Buchwald M. Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum Molec Genet. 1993;2:219-224.